ConductScience.org, home

Paper29356

Preparation of human leukocyte interferon for clinical use.

Cantell K and 1 other. Tex Rep Biol Med, 1977. Cited by 89 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Preparation of human leukocyte interferon for clinical use. Papers, record 29356. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29356

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Preparation of human leukocyte interferon for clinical use.
PubMed
Journal
Tex Rep Biol Med
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
89
iCite
Relative citation ratio, by iCite
3.41
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cantell KK
2Hirvonen SS

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
InterferonsMajor topic
LeukocytesMajor topic
Chemical Precipitation
Cold Temperature
Ethanol
Humans
Hydrogen-Ion Concentration
Thiocyanates

Source PubMed

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.

PMIDTitleJournalYearIn PapersSource
6,477,131Purification of human leukocyte interferon alpha by carboxymethyl controlled pore glass bead chromatography.Arch Virol1984https://conductscience.org/library/papers/6477131PubMed
6,301,405Characteristics of spontaneously produced and of virus-induced human LuKII cell interferons.Arch Virol1983https://conductscience.org/library/papers/6301405PubMed
6,222,855Humoral immune response in aged humans: suppressor effect of monocytes on spontaneous plaque forming cell generation.Clin Exp Immunol1983https://conductscience.org/library/papers/6222855PubMed
6,182,105Use of an anti-human leukocyte interferon monoclonal antibody for the purification and radioimmunoassay of human alpha interferon.Infect Immun1982https://conductscience.org/library/papers/6182105PubMed
6,176,663Interferon inhibits the generation of allospecific suppressor T lymphocytes.J Exp Med1982https://conductscience.org/library/papers/6176663PubMed
6,165,322Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6165322PubMed
6,155,349Inhibition by interferon of Sendai virus cytolysis.Infect Immun1980https://conductscience.org/library/papers/6155349PubMed
6,084,313Interferons, a group of multiple lymphokines.Springer Semin Immunopathol1984https://conductscience.org/library/papers/6084313PubMed
3,925,974The effects of alpha and gamma interferons on human lung cancer cells grown in vitro or as xenografts in nude mice.Br J Cancer1985https://conductscience.org/library/papers/3925974PubMed
2,425,443Interferons: current status and future directions of this prototypic biological.Springer Semin Immunopathol1986https://conductscience.org/library/papers/2425443PubMed
40,881Large-scale production and physicochemical characterization of human immune interferon.Infect Immun1979https://conductscience.org/library/papers/40881PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29356

GET https://conductscience.org/api/papers/v1/29356/authors